<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="hsn1" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">hsn1</book-part-id>
      <title-group>
        <title>Hereditary Sensory Neuropathy Type IA</title>
        <alt-title alt-title-type="alt-title">Synonyms: HSAN1A, HSN1A, Hereditary Sensory and Autonomic Neuropathy Type IA</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nicholson</surname>
            <given-names>Garth A</given-names>
          </name>
          <degrees>MB BS, PhD</degrees>
          <aff>Department of Medicine <break/>University of Sydney <break/>Hereditary Neuropathies Clinic and Molecular Medicine Laboratory<break/>Concord Hospital<break/>Sidney, Australia</aff>
          <email>garthn@usyd.edu.au</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>23</day>
          <month>9</month>
          <year>2002</year>
        </date>
        <date date-type="updated">
          <day>10</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="revised">
          <day>3</day>
          <month>5</month>
          <year>2012</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="hsan2" document-type="chapter">Hereditary Sensory and Autonomic Neuropathy Type II</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="hsp" document-type="chapter">Hereditary Spastic Paraplegia Overview</related-object>
      <abstract id="hsn1.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Hereditary sensory neuropathy type IA (HSN1A) is an axonal form of hereditary motor and sensory neuropathy distinguished by prominent early sensory loss and later positive sensory phenomena including dysesthesia and characteristic "lightning" or "shooting" pains. Loss of sensation can lead to painless injuries, which, if unrecognized, result in slow wound healing and subsequent osteomyelitis requiring distal amputations. HSN1A is often associated with progressive sensorineural deafness. Motor involvement is present in all advanced cases and can be severe. After age 20 years, the distal wasting and weakness may involve proximal muscles so that a person in his/her 60s or 70s may require a wheelchair for mobility. Drenching sweating of the hands and feet is sometimes reported and occasionally pupillary abnormalities are observed; however, visceral signs of autonomic involvement are rare.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The clinical diagnosis of HSN1A is based on the presence of prominent sensory loss with foot ulcers and shooting pains in one or more affected members of a family with what appears to be a CMT2 syndrome (i.e., axonal form of hereditary motor and sensory neuropathy). The diagnosis is established by identification of a heterozygous pathogenic variant in <italic toggle="yes">SPTLC1</italic>.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: Clean and protect wounds on neuropathic limbs; surgical treatment similar to that for leprosy; arthrodesis for Charcot joints; ankle/foot orthotics (AFOs) for foot drop; carbamazepine, gabapentin, or amitryptiline, or a combination of an antiepileptic drug and an antidepressant drug for shooting pains.</p>
          <p><italic toggle="yes">Prevention of secondary complications</italic>: Routine care by a diabetic foot care specialist to prevent/treat calluses and foot ulcers; education about good skin care and burn prevention (e.g., to hands when cooking).</p>
          <p><italic toggle="yes">Surveillance</italic>: At least daily inspection of feet for injuries or sources of wear.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid</italic>: Opiates as they are addicting and HSN1A is a chronic disorder.</p>
          <p><italic toggle="yes">Other</italic>: Tendon transposition surgery is not likely to be useful as weakness of the posterior lower leg muscles may occur.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>HSN1A is inherited in an autosomal dominant manner. Most probands have an affected parent. Offspring of an affected individual have a 50% chance of inheriting the <italic toggle="yes">SPTLC1</italic> pathogenic variant. Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant has been identified in the family.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="hsn1.Diagnosis">
        <title>Diagnosis</title>
        <p>No formal diagnostic criteria have been published.</p>
        <sec id="hsn1.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Hereditary sensory neuropathy type IA (HSN1A) <bold>should be suspected</bold> in individuals with the following clinical findings and family history:</p>
          <list list-type="bullet">
            <list-item>
              <p>Initial sensory neuropathy that then becomes a motor and sensory axonal neuropathy</p>
            </list-item>
            <list-item>
              <p>Painless injuries in the feet and hands with skin ulceration, Charcot joints, sometimes amputations</p>
            </list-item>
            <list-item>
              <p>Distal muscle weakness that spreads proximally producing limb girdle weakness in advanced stages</p>
            </list-item>
            <list-item>
              <p>At some stage, occurrence of typical sharp shooting &#x0201c;lightening&#x0201d; pains lasting seconds to minutes</p>
            </list-item>
            <list-item>
              <p>Sensorineural hearing loss (variably present)</p>
            </list-item>
            <list-item>
              <p>Family history consistent with autosomal dominant inheritance</p>
            </list-item>
          </list>
        </sec>
        <sec id="hsn1.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of HSN1A <bold>is established</bold> in a proband with suggestive clinical findings and identification of a heterozygous pathogenic variant in <italic toggle="yes">SPTLC1</italic> on molecular genetic testing (see <xref ref-type="table" rid="hsn1.T.summary_of_molecular_genetic_test">Table 1</xref>).</p>
          <p>Molecular testing approaches can include <bold>single-gene testing,</bold> use of a <bold>multi-gene panel,</bold> and <bold>more comprehensive</bold>
<bold>genomic testing.</bold></p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Molecular genetic testing of <italic toggle="yes">SPTLC1</italic> may begin with sequence analysis of exons 5 and 6. If no pathogenic variant is identified, further sequence analysis of <italic toggle="yes">SPTLC1</italic> may be considered. However, only gain-of-function pathogenic variants affecting the SPT active site and the SPTLC2 subunit of the SPT dimer cause the phenotype. Note: No duplications or deletions have been found or are expected given the disease mechanism.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">SPTLC1</italic> and other genes of interest (see <xref ref-type="sec" rid="hsn1.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included and sensitivity of multi-gene panels vary by laboratory and over time.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing, genome sequencing, and mitochondrial sequencing may be considered if single-gene testing (and/or use of a multi-gene panel) fails to confirm a diagnosis in an individual with features of HSN1A. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="hsn1.T.summary_of_molecular_genetic_test" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Hereditary Sensory Neuropathy Type IA</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_1_2">Test Method</th>
                  <th id="hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_1_3" colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method&#x000a0;<sup>3</sup></th>
                </tr>
                <tr>
                  <th headers="hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_1_3" id="hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Positive family history</th>
                  <th headers="hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_1_3" id="hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Negative family history</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">SPTLC1</italic>
                  </td>
                  <td headers="hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup> of select exons&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_1_3 hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">7 families (86%)</td>
                  <td headers="hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_1_3 hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">N/A</td>
                </tr>
                <tr>
                  <td headers="hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>4,&#x000a0;6</sup></td>
                  <td headers="hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_1_3 hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">N/A</td>
                  <td headers="hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_1_3 hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">10 families (10%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>7</sup></td>
                  <td headers="hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_1_3 hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_2_1 hd_h_hsn1.T.summary_of_molecular_genetic_test_1_1_2_2" valign="middle" colspan="2" align="left" rowspan="1">NA&#x000a0;<sup>8</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="hsn1.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="hsn1" object-id="hsn1.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="hsn1.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="hsn1.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="hsn1.TF.1.3">
                <label>3. </label>
                <p><xref ref-type="bibr" rid="hsn1.REF.houlden.2006.411">Houlden et al [2006]</xref>; Author, personal communication</p>
              </fn>
              <fn id="hsn1.TF.1.4">
                <label>4. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="hsn1.TF.1.5">
                <label>5. </label>
                <p>Sequence variants in exon 5 (including <xref ref-type="table" rid="hsn1.T.selected_sptlc1_pathogenic_varian">p.Cys133Tyr</xref> and <xref ref-type="table" rid="hsn1.T.selected_sptlc1_pathogenic_varian">p.Cys133Trp</xref>) and exon 6 (<xref ref-type="table" rid="hsn1.T.selected_sptlc1_pathogenic_varian">p.Val144Asp</xref>) [<xref ref-type="bibr" rid="hsn1.REF.bejaoui.2001.261">Bejaoui et al 2001</xref>, <xref ref-type="bibr" rid="hsn1.REF.dawkins.2001.309">Dawkins et al 2001</xref>]</p>
              </fn>
              <fn id="hsn1.TF.1.6">
                <label>6. </label>
                <p>Sequence variants including the known pathogenic variants p.Cys133Tyr, p.Cys133Trp, and p.Val144Asp</p>
              </fn>
              <fn id="hsn1.TF.1.7">
                <label>7. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="hsn1.TF.1.8">
                <label>8. </label>
                <p>No duplications or deletions have been found or are expected as the disease mechanism involves a gain-of-function pathogenic variant of the active site of the enzyme.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="hsn1.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="hsn1.Clinical_Description">
          <title>Clinical Description</title>
          <p>Hereditary sensory neuropathy type IA (HSN1A) is usually first noticed when painless injuries appear. Onset ranges from the teens to the sixth decade. Later, positive sensory phenomena occur (numbness, paresthesia, burning, and shooting pains). Shooting pains may be a distinctive but variable feature of HSN1.</p>
          <p>If the sensory loss is unheeded, chronic ulcerations of the extremities may lead to osteomyelitis and require amputations. Neuropathic joints are common.</p>
          <p>Weakness commences in the distal lower limbs, followed by the distal upper limbs and in severe cases, proximal upper- and lower-limb girdle muscles. Distal muscle weakness and wasting are present in all advanced cases. The weakness of ankle flexors produces a floppy, flipper-like foot rather than <italic toggle="yes">pes cavus</italic>.</p>
          <p>A few instances of early severe motor involvement have been reported [<xref ref-type="bibr" rid="hsn1.REF.houlden.2006.411">Houlden et al 2006</xref>].</p>
          <p>Older affected individuals may require wheelchairs for mobility.</p>
          <p>Retained and even brisk proximal reflexes in some affected individuals may indicate some upper motor neuron involvement. Corticospinal degeneration was not observed in an autopsied case with a known <italic toggle="yes">SPTLC1</italic> pathogenic variant, but data are limited.</p>
          <p>Sensorineural hearing loss is variable. When present, its onset is in middle to late adulthood.</p>
          <p>Rarely, pupillary abnormalities termed "tonic pupils" or pseudo-Argyll-Robertson pupils (i.e., those not associated with syphilis) are present.</p>
          <p>Visceral autonomic features are rare [Nicholson, unpublished data], with abdominal pain, diarrhea, and weight loss reported in some individuals in one family only [<xref ref-type="bibr" rid="hsn1.REF.houlden.2006.411">Houlden et al 2006</xref>].</p>
          <p><bold>Electrophysiology</bold> is initially normal and is not useful for early detection [Author, personal observation].</p>
          <list list-type="bullet">
            <list-item>
              <p>Sensory nerve action potentials are reduced only late in the disease.</p>
            </list-item>
            <list-item>
              <p>Motor nerve conduction velocities are normal until motor action potential amplitudes become reduced.</p>
            </list-item>
            <list-item>
              <p>Motor nerve conduction velocities are mildly slowed and motor action potentials are reduced in advanced cases.</p>
            </list-item>
          </list>
          <p><bold>Sural nerve biopsy</bold> shows axonal degeneration with loss of both small and large fibers. These findings are nonspecific and not diagnostic.</p>
        </sec>
        <sec id="hsn1.Neuropathology">
          <title>Neuropathology</title>
          <p>The disease process affects the axons and cell bodies of dorsal root ganglia neurons and motor neurons in the anterior horns of the spinal cord. Studies show a distal axonal degeneration with loss of unmyelinated, small myelinated, and large myelinated fibers with decreasing severity in that order, proceeding to ganglion cell loss [<xref ref-type="bibr" rid="hsn1.REF.houlden.2006.411">Houlden et al 2006</xref>]. See review in <xref ref-type="bibr" rid="hsn1.REF.thomas.1993.157">Thomas [1993]</xref>.</p>
        </sec>
        <sec id="hsn1.Penetrance">
          <title>Penetrance</title>
          <p>Variable penetrance has been observed [<xref ref-type="bibr" rid="hsn1.REF.houlden.2006.411">Houlden et al 2006</xref>].</p>
        </sec>
        <sec id="hsn1.Anticipation">
          <title>Anticipation</title>
          <p>An earlier age of onset in younger generations was noted in one study [<xref ref-type="bibr" rid="hsn1.REF.houlden.2006.411">Houlden et al 2006</xref>]; however, this could have been due to better recognition of the phenotype as earlier age of onset in younger generations has not been reported in any other publication.</p>
        </sec>
        <sec id="hsn1.Nomenclature">
          <title>Nomenclature</title>
          <p>The clinical classification of HSN1 has always been confusing. The term hereditary sensory neuropathy (HSN) was first used by <xref ref-type="bibr" rid="hsn1.REF.hicks.1922.319">Hicks [1922]</xref> to describe a family with associated spontaneous shooting pains and deafness. The family was later reported as having a form of peroneal muscular atrophy.</p>
          <p>Motor involvement was also noted in other families in southern England and described by Ellison in his University of Edinburgh MD thesis, and later by <xref ref-type="bibr" rid="hsn1.REF.campbell.1964.67">Campbell &#x00026; Hoffman [1964]</xref>. The Australian families with an <italic toggle="yes">SPTLC1</italic> pathogenic variant described in the original linkage and mutation reports [<xref ref-type="bibr" rid="hsn1.REF.dawkins.2001.309">Dawkins et al 2001</xref>] have no visceral autonomic symptoms and signs and share a common ancestor with the southern English families described by Ellison and reported by <xref ref-type="bibr" rid="hsn1.REF.campbell.1964.67">Campbell &#x00026; Hoffman [1964]</xref> as having HSN. Therefore, the term HSN has been used here as in the review by <xref ref-type="bibr" rid="hsn1.REF.thomas.1993.157">Thomas [1993]</xref> and as listed in OMIM. Rarely, individuals with HSN1 have autonomic pupillary and bladder signs; thus, this disorder has been classified as a hereditary sensory and autonomic neuropathy (HSAN).</p>
          <p>The term HSN is also less than ideal, as the disorder is a sensory and <italic toggle="yes">motor</italic> neuropathy. Therefore, strictly, it is a form of Charcot-Marie-Tooth neuropathy. The clinical appearance is that of a slowly progressive length-dependent adult-onset <related-object link-type="booklink" source-id="gene" document-id="cmt2" document-type="chapter">axonal form of Charcot-Marie-Tooth neuropathy</related-object> (CMT type II, hereditary motor and sensory neuropathy, HMSN II) with dense sensory loss.</p>
          <p>The term HSN1 designates <italic toggle="yes">dominantly</italic> inherited forms of hereditary sensory neuropathy. HSAN types 2 to 6 are recessively inherited forms of sensory and autonomic neuropathies.</p>
        </sec>
        <sec id="hsn1.Prevalence">
          <title>Prevalence</title>
          <p>An absolute figure cannot be given, but HSN affects 25 of 600 families (4.2%) with CMT studied by the author. Of these families with HSN, only 25% have HSN1A (1% of all families with CMT).</p>
          <p>If the overall incidence of motor and sensory neuropathies is 30:100,000, the prevalence of HSN is on the order of 2:1,000,000. HSN1A may be underestimated because diagnosis previously depended erroneously on finding pure sensory involvement, shooting pains, and/or skin damage or ulcers.</p>
        </sec>
      </sec>
      <sec id="hsn1.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">SPTLC1</italic>.</p>
      </sec>
      <sec id="hsn1.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Dominant forms of hereditary sensory neuropathy (HSN) are genetically heterogeneous:</p>
        <list list-type="bullet">
          <list-item>
            <p>HSAN1B (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/608088">608088</ext-link>), a dominantly inherited sensory neuropathy without foot ulcers but with cough and gastroesophageal reflux disease, maps to chromosome 3p24-p22 [<xref ref-type="bibr" rid="hsn1.REF.kok.2003.632">Kok et al 2003</xref>].</p>
          </list-item>
          <list-item>
            <p>HSAN1C (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/613640">613640</ext-link>) is caused by mutation of <italic toggle="yes">SPTLC2</italic> (encoding serine palmitoyl transferase subunit 2 of the dimer) and located on chromosome 14q24. The neuropathy is phenotypically similar but without autonomic signs</p>
          </list-item>
          <list-item>
            <p>HSN1D (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/613708">613708</ext-link>) is caused by mutation of <italic toggle="yes">ATL1</italic> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/606439">606439</ext-link>) on 14q.</p>
          </list-item>
          <list-item>
            <p>HSN1E (<related-object link-type="booklink" source-id="gene" document-id="dnmt1-ddsn" document-type="chapter">hereditary sensory neuropathy with dementia and hearing loss</related-object>), a late-onset mild sensory neuropathy associated with ataxia and deafness, is caused by mutation of <italic toggle="yes">DNMT1</italic> [<xref ref-type="bibr" rid="hsn1.REF.klein.2011.595">Klein et al 2011</xref>].</p>
          </list-item>
          <list-item>
            <p>The families with a dominantly inherited sensory neuropathy that is not linked to chromosome 9 [<xref ref-type="bibr" rid="hsn1.REF.auergrumbach.2000.45">Auer-Grumbach et al 2000</xref>, <xref ref-type="bibr" rid="hsn1.REF.bellone.2002.286">Bellone et al 2002</xref>] do not have shooting pains.</p>
          </list-item>
          <list-item>
            <p>Some families do not link to either the chromosome 9 or the chromosome 3 locus [<xref ref-type="bibr" rid="hsn1.REF.auergrumbach.2003.329">Auer-Grumbach et al 2003</xref>].</p>
          </list-item>
        </list>
        <p>Disorders with similar phenotypes are two forms of <related-object link-type="booklink" source-id="gene" document-id="cmt2" document-type="chapter">CMT2</related-object>:</p>
        <list list-type="bullet">
          <list-item>
            <p>CMT2B, a motor and sensory neuropathy with severe sensory loss and foot ulcers but no shooting pains, described by <xref ref-type="bibr" rid="hsn1.REF.kwon.1995.853">Kwon et al [1995]</xref>. CMT2B is caused by mutation of <italic toggle="yes">RAB7</italic> [<xref ref-type="bibr" rid="hsn1.REF.verhoeven.2003.722">Verhoeven et al 2003</xref>].</p>
          </list-item>
          <list-item>
            <p>CMT2I/J. The <italic toggle="yes">MPZ</italic> p.Thr124Met pathogenic variant is associated with a phenotype almost identical to HSN1A, with severe sensory loss, shooting pains, and occasional pseudo Argyl-Robertson pupils but no ulcerations [<xref ref-type="bibr" rid="hsn1.REF.de_jonghe.1999.281">De Jonghe et al 1999</xref>].</p>
          </list-item>
        </list>
        <p>Painful diabetic neuropathy may have a similar phenotype but usually lacks a family history of neuropathy.</p>
        <p>See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS162400?sort=phenotype">Hereditary sensory and autonomic neuropathy: OMIM Phenotypic Series</ext-link> to view genes associated with this phenotype in OMIM.</p>
      </sec>
      <sec id="hsn1.Management">
        <title>Management</title>
        <sec id="hsn1.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with hereditary sensory neuropathy type IA, the following assessments are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Feet, ankles, and hands re the condition of the skin</p>
            </list-item>
            <list-item>
              <p>Joints for evidence of Charcot joints</p>
            </list-item>
            <list-item>
              <p>Strength</p>
            </list-item>
            <list-item>
              <p>Loss of sweating and compensatory patchy hyperhydrosis</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="hsn1.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Wounds on neuropathic limbs heal if they are clean and protected and the limb is rested. Principles of treatment are the same as for leprosy surgery; see <xref ref-type="bibr" rid="hsn1.REF.warren.1999">Warren &#x00026; Nade [1999]</xref>.</p>
          <p>Foot drop can be treated with ankle/foot orthotics (AFOs), but these need sleeving with stockings or some form of second skin to prevent skin abrasion.</p>
          <p>Charcot joints may require arthrodesis.</p>
          <p>Shooting pains are difficult to treat and only partial relief can be obtained with carbamazepine, gabapentin, or amitryptiline, or a combination of an antiepileptic and an antidepressant. Opiates are contraindicated as HSN1A is a chronic disorder.</p>
        </sec>
        <sec id="hsn1.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>Foot ulcers are frequently caused by breakdown of callus. Therefore, it is important to prevent callus formation by removing sources of pressure and to treat existing callus by softening the skin. Routine foot care by a diabetic clinic or by a podiatrist instructed to treat as for a diabetic foot is recommended.</p>
          <p>Burns can be prevented by using gloves as needed (e.g., during cooking).</p>
          <p>A diabetic education clinic is an excellent source of advice regarding skin care.</p>
        </sec>
        <sec id="hsn1.Surveillance">
          <title>Surveillance</title>
          <p>Feet should be inspected at least daily for injuries or sources of wear.</p>
        </sec>
        <sec id="hsn1.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Opiates are contraindicated as this is a chronic disorder.</p>
        </sec>
        <sec id="hsn1.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="hsn1.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="hsn1.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p><xref ref-type="bibr" rid="hsn1.REF.penno.2010.11178">Penno et al [2010]</xref> found that HSN1A-causing pathogenic variants in <italic toggle="yes">SPTLC1</italic> result in decreased specificity of the active site of the enzyme, allowing alanine and glycine into the active site and producing neurotoxic sphingoid bases. The finding suggests that HSN1A is caused by these toxic products and opens an avenue for possible (at present, experimental) therapeutic approaches. Addition of serine to the diet of an HSN1 animal model and to 14 humans with HSN1 was effective in reducing plasma levels of the toxic deoxysphingolipids [<xref ref-type="bibr" rid="hsn1.REF.garofalo.2011.4735">Garofalo et al 2011</xref>].</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="hsn1.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="hsn1.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Hereditary sensory neuropathy type IA (HSN1A) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="hsn1.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals diagnosed with HSN1A have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with HSN1A may have the disorder as the result of a <italic toggle="yes">de novo</italic>
<italic toggle="yes">SPTLC1</italic> pathogenic variant. One apparent <italic toggle="yes">de novo</italic> pathogenic variant has been reported [<xref ref-type="bibr" rid="hsn1.REF.verhoeven.2004.1001">Verhoeven et al 2004</xref>]; the proportion of HSN1A caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, two possible explanations are germline mosaicism in a parent or a <italic toggle="yes">de novo</italic> pathogenic variant in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility.</p>
            </list-item>
            <list-item>
              <p>Although recommendations for evaluation of the parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include clinical examination and electrophysiologic testing, diagnostic clinical and electrophysiologic findings have not been reported to emerge after age 30 years.</p>
            </list-item>
            <list-item>
              <p>The family history of some individuals diagnosed with HSN1A may appear to be negative because of failure to recognize the disorder in family members, reduced penetrance, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate clinical evaluation and/or molecular genetic testing have been performed on the parents of the proband.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to each sib of the proband depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to each sib is 50%.</p>
            </list-item>
            <list-item>
              <p>If the parents of a proband are clinically unaffected, sibs who are younger than age 30 years are still at increased risk for HSN1A because of the possibility of reduced penetrance in a parent.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">SPTLC1</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism. Germline mosaicism has not been reported to date.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an affected individual has a 50% chance of inheriting the <italic toggle="yes">SPTLC1</italic> pathogenic variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents: if a parent is affected, his or her family members are at risk.</p>
        </sec>
        <sec id="hsn1.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Testing of at-risk asymptomatic adult relatives</bold> of individuals with HSN1A is possible after molecular genetic testing has identified the specific pathogenic variant in the family. Such testing should be performed in the context of formal genetic counseling, and is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. Testing of asymptomatic at-risk individuals with nonspecific or equivocal symptoms is predictive testing, not diagnostic testing.</p>
          <p><bold>Testing of asymptomatic individuals younger than age 18 years</bold> who are at risk for adult-onset disorders for which no treatment exists is not considered appropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</p>
          <p>If a diagnosis of HSN1A has been established in the family, it is appropriate to consider testing of symptomatic individuals regardless of age.</p>
          <p>For more information, see the National Society of Genetic Counselors <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">position statement</ext-link> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">policy statement</ext-link>: ethical and policy issues in genetic testing and screening of children.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with HSN1A has the <italic toggle="yes">SPTLC1</italic> pathogenic variant or clinical evidence of the disorder, the pathogenic variant is likely <italic toggle="yes">de novo</italic>. However, other possible non-medical explanations that could also be explored include alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="hsn1.Prenatal_Testing_and_Preimplantatio">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">SPTLC1</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for HSN1A are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="hsn1.Resources">
        <title>Resources</title>
      </sec>
      <sec id="hsn1.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="hsn1.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p><bold>Gene structure.</bold> The <italic toggle="yes">SPTLC1</italic> reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_006415.3">NM_006415.3</ext-link> is the longest transcript variant and has 15 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="hsn1" object-id="hsn1.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic variants.</bold> The following three pathogenic variants result in significant amino acid changes likely to have functional or structural effects.</p>
          <list list-type="bullet">
            <list-item>
              <p>The most common pathogenic variant, p.Cys133Trp in exon 5, was found in English and Canadian families and in US and Australian families of English origin [<xref ref-type="bibr" rid="hsn1.REF.bejaoui.2001.261">Bejaoui et al 2001</xref>, <xref ref-type="bibr" rid="hsn1.REF.dawkins.2001.309">Dawkins et al 2001</xref>].</p>
            </list-item>
            <list-item>
              <p>The pathogenic variant affecting the same codon, p.Cys133Tyr, was described in two families of Austrian and German origin [<xref ref-type="bibr" rid="hsn1.REF.bejaoui.2001.261">Bejaoui et al 2001</xref>, <xref ref-type="bibr" rid="hsn1.REF.dawkins.2001.309">Dawkins et al 2001</xref>].</p>
            </list-item>
            <list-item>
              <p>The pathogenic variant p.Val144Asp in exon 6 was found in two Australian families of English and Scottish origins.</p>
            </list-item>
          </list>
          <p><bold>Variant of uncertain significance.</bold> A p.Gly387Ala (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?type=rs&#x00026;rs=rs119482084">rs119482084</ext-link>; OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/605712">605712</ext-link>) variant was identified in two sisters of Belgian origin [<xref ref-type="bibr" rid="hsn1.REF.verhoeven.2004.1001">Verhoeven et al 2004</xref>]; their parents were not available for testing. Since this change has been observed in the general population and in the homozygous state in a parent of an affected person [<xref ref-type="bibr" rid="hsn1.REF.hornemann.2009.135">Hornemann et al 2009</xref>], it is unlikely to be pathogenic.</p>
          <table-wrap id="hsn1.T.selected_sptlc1_pathogenic_varian" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Selected <italic toggle="yes">SPTLC1</italic> Pathogenic Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_hsn1.T.selected_sptlc1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_hsn1.T.selected_sptlc1_pathogenic_varian_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                  <th id="hd_h_hsn1.T.selected_sptlc1_pathogenic_varian_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_hsn1.T.selected_sptlc1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.399T&#x0003e;G</td>
                  <td headers="hd_h_hsn1.T.selected_sptlc1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys133Trp</td>
                  <td headers="hd_h_hsn1.T.selected_sptlc1_pathogenic_varian_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_006415.2">NM_006415.2</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_006406.1">NP_006406.1</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_hsn1.T.selected_sptlc1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.398G&#x0003e;A</td>
                  <td headers="hd_h_hsn1.T.selected_sptlc1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys133Tyr</td>
                </tr>
                <tr>
                  <td headers="hd_h_hsn1.T.selected_sptlc1_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.431T&#x0003e;A</td>
                  <td headers="hd_h_hsn1.T.selected_sptlc1_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val144Asp</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> The serine palmitoyltransferase light chain 1 has 473 amino acids.</p>
          <p><bold>Abnormal gene product.</bold> Pathogenic variants in the active sites of the <italic toggle="yes">SPTLC1</italic> and <italic toggle="yes">SPTLC2</italic> subunits result in a gain-of-function by altering substrate specificity allowing alanine and glycine to be incorporated into new toxic sphingolipids which cannot be degraded, leading to the accumulation of the toxic lipids 1-deoxy-sphinganine and 1-deoxymethyl-sphinganine. Raised levels of toxic deoxy-sphingoid bases (DSBs) 1-deoxy-sphinganine and 1-deoxymethyl-sphinganine have recently been reported in HSN1A plasma [<xref ref-type="bibr" rid="hsn1.REF.penno.2010.11178">Penno et al 2010</xref>].</p>
          <p>Expression of the mutated gene product has not been investigated.</p>
          <p>Overexpression of the wild type allele in a mouse model of HSN1A has reversed the phenotype [<xref ref-type="bibr" rid="hsn1.REF.eichler.2009.14646">Eichler et al 2009</xref>]. This finding opens the prospect of possible treatments aimed at reducing the levels of these metabolites.</p>
        </sec>
      </sec>
      <sec id="hsn1.References">
        <title>References</title>
        <sec id="hsn1.Published_GuidelinesConsensus_State">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="hsn1.Published_GuidelinesConsensus_State.reflist0">
            <ref id="hsn1.REF1">
              <mixed-citation publication-type="web">Committee on Bioethics; Committee on Genetics, and American College of Medical Genetics and Genomics: Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">online</ext-link>. Accessed 2-21-17.</mixed-citation>
            </ref>
            <ref id="hsn1.REF2">
              <mixed-citation publication-type="web">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">online</ext-link>. 2012. Accessed 2-21-17</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="hsn1.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="hsn1.Literature_Cited.reflist0">
            <ref id="hsn1.REF.auergrumbach.2003.329">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Auer-Grumbach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verhoeven</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartung</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>GA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Autosomal dominant inherited neuropathies with prominent sensory loss and mutilations: a review.</article-title>
                <source>Arch Neurol</source>
                <volume>60</volume>
                <fpage>329</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">12633143</pub-id>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.auergrumbach.2000.45">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Auer-Grumbach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartung</surname>
                    <given-names>HP</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Ulcero-mutilating neuropathy in an Austrian kinship without linkage to hereditary motor and sensory neuropathy IIB and hereditary sensory neuropathy I loci.</article-title>
                <source>Neurology</source>
                <volume>54</volume>
                <fpage>45</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">10636124</pub-id>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.bejaoui.2001.261">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bejaoui</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffler</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashby</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Jong</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>SPTLC1 is mutated in hereditary sensory neuropathy, type 1.</article-title>
                <source>Nat Genet</source>
                <volume>27</volume>
                <fpage>261</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">11242106</pub-id>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.bellone.2002.286">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bellone</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodolico</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toscano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Maria</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassandrini</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pizzuti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pigullo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazzeo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macaione</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girlanda</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vita</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ajmar</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandich</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>A family with autosomal dominant mutilating neuropathy not linked to either Charcot-Marie-Tooth disease type 2B (CMT2B) or hereditary sensory neuropathy type I (HSN I) loci.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>12</volume>
                <fpage>286</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">11801401</pub-id>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.campbell.1964.67">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffman</surname>
                    <given-names>HL</given-names>
                  </name>
                </person-group>
                <year>1964</year>
                <article-title>Sensory radicular neuropathy associated with muscle wasting in two cases.</article-title>
                <source>Brain</source>
                <volume>87</volume>
                <fpage>67</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">14152213</pub-id>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.dawkins.2001.309">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dawkins</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulme</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brahmbhatt</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auer-Grumbach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>GA</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I.</article-title>
                <source>Nat Genet</source>
                <volume>27</volume>
                <fpage>309</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">11242114</pub-id>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.de_jonghe.1999.281">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceuterick</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vriendt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lofgren</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vercruyssen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verellen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Maldergem</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype.</article-title>
                <source>Brain</source>
                <volume>122</volume>
                <fpage>281</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">10071056</pub-id>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.eichler.2009.14646">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eichler</surname>
                    <given-names>FS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hornemann</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCampbell</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuljis</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penno</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vardeh</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamrazian</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garofalo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selig</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frosch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gable</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Eckardstein</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woolf</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guan</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harmon</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunn</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1.</article-title>
                <source>J Neurosci.</source>
                <volume>29</volume>
                <fpage>14646</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">19923297</pub-id>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.garofalo.2011.4735">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garofalo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penno</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frosch</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Eckardstein</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hornemann</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eichler</surname>
                    <given-names>FS</given-names>
                  </name>
                </person-group>
                <article-title>Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1.</article-title>
                <source>J Clin Invest.</source>
                <year>2011</year>
                <volume>121</volume>
                <fpage>4735</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">22045570</pub-id>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.hicks.1922.319">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hicks</surname>
                    <given-names>EP</given-names>
                  </name>
                </person-group>
                <year>1922</year>
                <article-title>Hereditary perforating ulcer of the foot.</article-title>
                <source>Lancet</source>
                <volume>1</volume>
                <fpage>319</fpage>
                <lpage>21</lpage>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.hornemann.2009.135">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hornemann</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penno</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dijk</surname>
                    <given-names>FS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rotthier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Eckardstein</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>A systematic comparison of all mutations in hereditary sensory neuropathy type I (HSAN I) reveals that the G387A mutation is not disease associated.</article-title>
                <source>Neurogenetics.</source>
                <year>2009</year>
                <volume>10</volume>
                <fpage>135</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">19132419</pub-id>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.houlden.2006.411">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Houlden</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blake</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Groves</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Love</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammans</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicoll</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lennox</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Donovan</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabriel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reilly</surname>
                    <given-names>MM</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Clinical, pathological and genetic characterization of hereditary sensory and autonomic neuropathy type 1 (HSAN I).</article-title>
                <source>Brain</source>
                <volume>129</volume>
                <fpage>411</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">16364956</pub-id>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.klein.2011.595">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Botuyan</surname>
                    <given-names>MV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammans</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hojo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamanishi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karpf</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lander</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boardman</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cunningham</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Litchy</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boes</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atkinson</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Middha</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dyck</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parisi</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>DI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dyck</surname>
                    <given-names>PJ</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.</article-title>
                <source>Nat Genet.</source>
                <volume>43</volume>
                <fpage>595</fpage>
                <lpage>600</lpage>
                <pub-id pub-id-type="pmid">21532572</pub-id>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.kok.2003.632">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kok</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennerson</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spring</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ing</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollard</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>GA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A locus for hereditary sensory neuropathy with cough and gastroesophageal reflux on chromosome 3p22-p24.</article-title>
                <source>Am J Hum Genet</source>
                <volume>73</volume>
                <fpage>632</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12870133</pub-id>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.kwon.1995.853">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kwon</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elliott</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yee</surname>
                    <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ivanovich</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scavarda</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moolsintong</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodfellow</surname>
                    <given-names>PJ</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q.</article-title>
                <source>Am J Hum Genet</source>
                <volume>57</volume>
                <fpage>853</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">7573046</pub-id>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.penno.2010.11178">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Penno</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reilly</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlden</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laur&#x000e1;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rentsch</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niederkofler</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoeckli</surname>
                    <given-names>ET</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eichler</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>von Eckardstein</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hornemann</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids.</article-title>
                <source>J Biol Chem.</source>
                <volume>285</volume>
                <fpage>11178</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">20097765</pub-id>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.thomas.1993.157">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>PK</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Hereditary sensory neuropathies.</article-title>
                <source>Brain Pathol</source>
                <volume>3</volume>
                <fpage>157</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">8293177</pub-id>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.verhoeven.2004.1001">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verhoeven</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vriendt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobs</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Gerwen</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smouts</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pou-Serradell</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>SPTLC1 mutation in twin sisters with hereditary sensory neuropathy type I.</article-title>
                <source>Neurology</source>
                <volume>62</volume>
                <fpage>1001</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">15037712</pub-id>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.verhoeven.2003.722">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verhoeven</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verpoorten</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auer-Grumbach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwon</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>FitzPatrick</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmedding</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vriendt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobs</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Gerwen</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartung</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy.</article-title>
                <source>Am J Hum Genet</source>
                <volume>72</volume>
                <fpage>722</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12545426</pub-id>
              </element-citation>
            </ref>
            <ref id="hsn1.REF.warren.1999">
              <mixed-citation publication-type="book">Warren G, Nade S. <italic toggle="yes">The Care of Neuropathic Limbs: A Practical Manual.</italic> London and New York: Parthenon Publishing; 1999.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="hsn1.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="hsn1.Suggested_Reading.reflist0">
            <ref id="hsn1.REF.auergrumbach.2008.7">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Auer-Grumbach</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Hereditary sensory neuropathy type I.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <volume>3</volume>
                <fpage>7</fpage>
                <pub-id pub-id-type="pmid">18348718</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="hsn1.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="hsn1.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>10 September 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>7 March 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>3 May 2012 (gn) Revision: edits to <xref ref-type="sec" rid="hsn1.Therapies_Under_Investigation">Therapies Under Investigation</xref></p>
            </list-item>
            <list-item>
              <p>15 March 2012 (cd) Revision: targeted mutation analysis no longer listed as available clinically in the GeneTests&#x02122; Laboratory Directory</p>
            </list-item>
            <list-item>
              <p>22 September 2011 (cd) Revision: addition to Differential Diagnosis; change in disease nomenclature (HSN1 &#x02192; HSN1A)</p>
            </list-item>
            <list-item>
              <p>20 July 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>2 October 2007 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>11 March 2005 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>28 September 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>21 May 2004 (gn) Revision: prenatal testing available</p>
            </list-item>
            <list-item>
              <p>23 September 2002 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>21 March 2002 (gn) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
